Related Experiment Video
Updated: Sep 18, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Victor Gife1, Bahram Sharif-Askari2, Anavasadat Sadr Hashemi Nejad1
1Maisonneuve-Rosemont Hospital Research Centre; Department of Biochemistry and Molecular Medicine, University of Montreal.
Abstract:
To adapt and resist approved treatments, acute myeloid leukemia (AML) cells activate specific molecular pathways that lead to changes in gene expression, protein levels and activity. In this protocol, an approach is reported to explore targets phosphorylated downstream of oncogenic signaling in AML: p-STAT5 (Tyr694), p-4EBP1 (Thr37/46), p-RPS6 (Ser240/244), and p-ERK1/2 (Thr202/Tyr204). This method enables the assessment of how these pathways-major regulators of stemness maintenance, immune evasion, protein synthesis, and adaptation to oxidative and metabolic stress-are modulated by one or more tested compounds in bone marrow cells harvested from live mice by aspiration before and after the treatment phase. This minimally invasive method preserves cell integrity and reduces stress compared to bone-crushing techniques, which can induce damage and potentially affect experimental outcomes. To optimize intracellular antibody staining for flow cytometric analysis, a protocol was developed using paraformaldehyde fixation and methanol permeabilization. This approach ensures high staining precision and minimizes background noise, enabling reliable detection of intracellular signaling markers. One of the main advantages of this protocol is the development of a multiparametric antibody panel, allowing for simultaneous assessment of the four pathways within the same sample. Using a next-generation spectral flow cytometer with high sensitivity, dynamic shifts in pathway activation were observed depending on treatment conditions compared to pretreatment baseline levels in the same mice. This methodology enables precise in vivo analysis of signaling pathway modulation in patient-derived xenograft bone marrow samples without requiring euthanasia of the animals, providing valuable insight into the adaptive mechanisms of AML cells, and can guide the evaluation of therapeutic strategies aimed at targeting these pathways to overcome resistance.
Insights
This study introduces a minimally invasive method to analyze key signaling pathways in acute myeloid leukemia (AML) cells, revealing how treatments affect cancer adaptation and guiding new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Acute myeloid leukemia (AML) cells develop resistance to treatments by activating specific molecular pathways.
- Understanding these adaptive mechanisms is crucial for developing effective therapies.
Purpose of the Study:
- To report a protocol for assessing phosphorylated signaling targets in AML cells.
- To evaluate how compounds modulate key pathways regulating stemness, immune evasion, and stress adaptation.
Main Methods:
- Developed a minimally invasive bone marrow aspiration technique in live mice.
- Optimized intracellular antibody staining using paraformaldehyde fixation and methanol permeabilization.
- Created a multiparametric antibody panel for simultaneous assessment of p-STAT5, p-4EBP1, p-RPS6, and p-ERK1/2 via spectral flow cytometry.
Main Results:
- Observed dynamic shifts in pathway activation in response to treatment conditions.
- Demonstrated precise in vivo analysis of signaling modulation in patient-derived xenograft bone marrow samples.
- Showcased the ability to analyze samples before and after treatment from the same animal without euthanasia.
Conclusions:
- The developed methodology enables reliable detection of intracellular signaling markers in AML.
- This approach provides valuable insights into AML cell adaptation and resistance mechanisms.
- The protocol can guide the evaluation of targeted therapeutic strategies to overcome AML resistance.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018